Evol-biotech
Evol-biotech, a leading name in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and Europe. Founded in 2015, the company has rapidly established itself as a pioneer in biopharmaceutical development, focusing on innovative therapies and advanced drug delivery systems. Evol-biotech's core offerings include cutting-edge biologics and personalised medicine solutions, distinguished by their commitment to quality and efficacy. The company has achieved significant milestones, including successful collaborations with major research institutions and a robust pipeline of clinical trials. With a strong market position, Evol-biotech is recognised for its contributions to the industry, driving advancements in healthcare and improving patient outcomes through its unique approach to biotechnology.
DitchCarbon Score
How does Evol-biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Evol-biotech's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Evol-biotech's reported carbon emissions
Evol-biotech, headquartered in CN, currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. However, the company is committed to addressing climate change through various initiatives, although no specific reduction targets or climate pledges have been disclosed. In the absence of concrete data, it is essential to monitor Evol-biotech's future commitments and actions in the context of industry standards for sustainability and carbon reduction.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Evol-biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
